Literature DB >> 19773263

Hepcidin targets ferroportin for degradation in hepatocytes.

Guillemette Ramey1, Jean-Christophe Deschemin, Béatrice Durel, François Canonne-Hergaux, Gaël Nicolas, Sophie Vaulont.   

Abstract

Hepcidin, a circulating regulatory hormone peptide produced by hepatocytes, functions as the master regulator of cellular iron export by controlling the amount of ferroportin, an iron exporter present on the basolateral surface of intestinal enterocytes and macrophages. Hepcidin binding to ferroportin induces its internalization and degradation, resulting in cellular iron retention and decreased iron export. Whether hepatocytes express ferroportin that could be targeted by hepcidin has remained a subject of debate. Here, we describe a hepatocyte culture system expressing high levels of ferroportin, and demonstrate that both endogenously secreted and synthetic hepcidin are fully active in down-regulating membrane-associated ferroportin. In agreement with this result, ferroportin is stabilized in liver hepatocytes of hepcidin-deficient mice and accumulates in periportal areas, supporting the centrolobular iron deposition observed in these mice. In conclusion, we show that hepcidin can trigger ferroportin degradation in hepatocytes, which must be taken into account when considering hepcidin therapeutics.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19773263      PMCID: PMC2833082          DOI: 10.3324/haematol.2009.014399

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  27 in total

1.  Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells.

Authors:  T Chaston; B Chung; M Mascarenhas; J Marks; B Patel; S K Srai; P Sharp
Journal:  Gut       Date:  2007-10-26       Impact factor: 23.059

2.  Transcripts of ceruloplasmin but not hepcidin, both major iron metabolism genes, exhibit a decreasing pattern along the portocentral axis of mouse liver.

Authors:  Marie-Bérengère Troadec; Alain Fautrel; Bernard Drénou; Patricia Leroyer; Emilie Camberlein; Bruno Turlin; André Guillouzo; Pierre Brissot; Olivier Loréal
Journal:  Biochim Biophys Acta       Date:  2008-01-03

3.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter.

Authors:  A Donovan; A Brownlie; Y Zhou; J Shepard; S J Pratt; J Moynihan; B H Paw; A Drejer; B Barut; A Zapata; T C Law; C Brugnara; S E Lux; G S Pinkus; J L Pinkus; P D Kingsley; J Palis; M D Fleming; N C Andrews; L I Zon
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

4.  Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process.

Authors:  Bruno Gagliardo; Nicole Kubat; Audrey Faye; Maryse Jaouen; Béatrice Durel; Jean-Christophe Deschemin; François Canonne-Hergaux; Marie-Agnès Sari; Sophie Vaulont
Journal:  J Hepatol       Date:  2008-12-04       Impact factor: 25.083

5.  The molecular mechanism of hepcidin-mediated ferroportin down-regulation.

Authors:  Ivana De Domenico; Diane McVey Ward; Charles Langelier; Michael B Vaughn; Elizabeta Nemeth; Wesley I Sundquist; Tomas Ganz; Giovanni Musci; Jerry Kaplan
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

6.  Autocrine formation of hepcidin induces iron retention in human monocytes.

Authors:  Igor Theurl; Milan Theurl; Markus Seifert; Sabine Mair; Manfred Nairz; Holger Rumpold; Heinz Zoller; Rosa Bellmann-Weiler; Harald Niederegger; Heribert Talasz; Günter Weiss
Journal:  Blood       Date:  2007-12-11       Impact factor: 22.113

7.  Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes.

Authors:  Guillemette Ramey; Jean-Christophe Deschemin; Sophie Vaulont
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

8.  Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis.

Authors:  Alicia R Folgueras; Fernando Martín de Lara; Alberto M Pendás; Cecilia Garabaya; Francisco Rodríguez; Aurora Astudillo; Teresa Bernal; Rubén Cabanillas; Carlos López-Otín; Gloria Velasco
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

9.  Lack of the bone morphogenetic protein BMP6 induces massive iron overload.

Authors:  Delphine Meynard; Léon Kautz; Valérie Darnaud; François Canonne-Hergaux; Hélène Coppin; Marie-Paule Roth
Journal:  Nat Genet       Date:  2009-03-01       Impact factor: 38.330

10.  Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin.

Authors:  Ivana De Domenico; Diane McVey Ward; Maria Carmela Bonaccorsi di Patti; Suh Young Jeong; Samuel David; Giovanni Musci; Jerry Kaplan
Journal:  EMBO J       Date:  2007-05-31       Impact factor: 11.598

View more
  60 in total

Review 1.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

2.  Molecular Characterisation of a Novel Isoform of Hepatic Antimicrobial Peptide, Hepcidin (Le-Hepc), from Leiognathus equulus and Analysis of Its Functional Properties In Silico.

Authors:  Aishwarya Nair; K S Sruthy; E R Chaithanya; T P Sajeevan; I S Bright Singh; Rosamma Philip
Journal:  Probiotics Antimicrob Proteins       Date:  2017-12       Impact factor: 4.609

Review 3.  Iron transport proteins: Gateways of cellular and systemic iron homeostasis.

Authors:  Mitchell D Knutson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

4.  Immunoassay-based serum hepcidin reference range measurements in healthy children: differences among age groups.

Authors:  Triantafyllia Sdogou; Charalampos Tsentidis; Dimitrios Gourgiotis; Antonios Marmarinos; Alexandra Gkourogianni; Ioannis Papassotiriou; Theodora Anastasiou; Lydia Kossiva
Journal:  J Clin Lab Anal       Date:  2014-03-22       Impact factor: 2.352

Review 5.  The liver: conductor of systemic iron balance.

Authors:  Delphine Meynard; Jodie L Babitt; Herbert Y Lin
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

6.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

7.  Ferroportin deficiency impairs manganese metabolism in flatiron mice.

Authors:  Young Ah Seo; Marianne Wessling-Resnick
Journal:  FASEB J       Date:  2015-03-17       Impact factor: 5.191

Review 8.  Ferroportin-mediated iron transport: expression and regulation.

Authors:  Diane M Ward; Jerry Kaplan
Journal:  Biochim Biophys Acta       Date:  2012-03-13

9.  Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS.

Authors:  Chang-Kyu Oh; Seong-Hwan Park; Juil Kim; Yuseok Moon
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

10.  TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.

Authors:  Pavel Zhabyeyev; Subhash K Das; Ratnadeep Basu; Mengcheng Shen; Vaibhav B Patel; Zamaneh Kassiri; Gavin Y Oudit
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.